restor3d increased its recent $14 million fund raise to $23 million. Proceeds will be used to expand the delivery of 3D-printed personalized surgical solutions across multiple musculoskeletal specialties, and to develop machine learning software tools to assist engineers with patient-specific implant design.
Capital will be deployed on:
New product introductions and enhanced 3D-printed personalized surgical solutions in upper/lower extremity, spine and trauma
Ongoing development of machine learning-enabled software for surgical planning and implant design
Research, preclinical and clinical studies
Expansion of the commercial team to support market traction
In addition, in early 2023, restor3d will move into a new facility in Research Triangle Park that will expand capabilities for patient-specific digital design, in-house manufacturing of implants and instruments, and surgeon training and education labs.
In 2021, restor3d announced its merger with Kinos Medical, a total ankle replacement company, which helped accelerate restor3d’s expansion into the U.S. extremity replacement market. restor3d has multiple FDA product clearances that span lower extremity, upper extremity, spine and trauma. The new funding and restor3d’s 3D-printed implant and disposable instrument model will enable simultaneous expansion across diverse markets.
restor3d increased its recent $14 million fund raise to $23 million. Proceeds will be used to expand the delivery of 3D-printed personalized surgical solutions across multiple musculoskeletal specialties, and to develop machine learning software tools to assist engineers with patient-specific implant design.
Capital will be deployed on:
...
restor3d increased its recent $14 million fund raise to $23 million. Proceeds will be used to expand the delivery of 3D-printed personalized surgical solutions across multiple musculoskeletal specialties, and to develop machine learning software tools to assist engineers with patient-specific implant design.
Capital will be deployed on:
New product introductions and enhanced 3D-printed personalized surgical solutions in upper/lower extremity, spine and trauma
Ongoing development of machine learning-enabled software for surgical planning and implant design
Research, preclinical and clinical studies
Expansion of the commercial team to support market traction
In addition, in early 2023, restor3d will move into a new facility in Research Triangle Park that will expand capabilities for patient-specific digital design, in-house manufacturing of implants and instruments, and surgeon training and education labs.
In 2021, restor3d announced its merger with Kinos Medical, a total ankle replacement company, which helped accelerate restor3d’s expansion into the U.S. extremity replacement market. restor3d has multiple FDA product clearances that span lower extremity, upper extremity, spine and trauma. The new funding and restor3d’s 3D-printed implant and disposable instrument model will enable simultaneous expansion across diverse markets.
Copy to clipboard 
